Verastem (VSTM) Change in Inventory (2018 - 2026)

Verastem's (VSTM) quarterly Change in Inventory came in at $454000.0 in Q1 2026, up 1064.1% quarter-over-quarter from $39000.0 in Q4 2025.

Verastem (VSTM) Change in Inventory (2018 - 2026) Analysis & Trends

Verastem's Change in Inventory history runs 5 years deep, the most recent figure standing at $454000.0 for Q1 2026.

On a quarterly basis, Change in Inventory changed N/A year-over-year to $454000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.8 million, changed N/A from the prior year.
Change in Inventory grew to $454000.0 in Q1 2026 per VSTM's latest filing, from $39000.0 in the prior quarter.
Across five years, Change in Inventory topped out at $626000.0 in Q3 2025 and bottomed at $39000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	71.84 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	97.70 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-26.60 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Verastem	166.09 Mn	-31.73 Mn	15.90 Mn	454,000.00

Download Data